Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

January 01, 1982; Volume 21,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aarbakke, J

    1. You have access
      Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purified rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine.
      P M Ueland, J Aarbakke and A Bessesen
      Molecular Pharmacology January 1982, 21 (1) 108-113;
  2. Abita, J P

    1. You have access
      Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP.
      C Gespach and J P Abita
      Molecular Pharmacology January 1982, 21 (1) 78-85;
  3. Abou-Donia, M B

    1. You have access
      Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
      K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia
      Molecular Pharmacology January 1982, 21 (1) 133-141;

B

  1. Balzarini, J

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;
  2. Banks, R B

    1. You have access
      Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
      P E Hanna, R B Banks and V C Marhevka
      Molecular Pharmacology January 1982, 21 (1) 159-165;
  3. Baum, B J

    1. You have access
      Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;
  4. Bergstrom, D E

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;
  5. Bessesen, A

    1. You have access
      Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purified rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine.
      P M Ueland, J Aarbakke and A Bessesen
      Molecular Pharmacology January 1982, 21 (1) 108-113;
  6. Bickers, D R

    1. You have access
      Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
      D R Bickers, T Dutta-Choudhury and H Mukhtar
      Molecular Pharmacology January 1982, 21 (1) 239-247;
  7. Borchardt, R T

    1. You have access
      Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
      R T Borchardt, D Kuonen, J A Huber and A Moorman
      Molecular Pharmacology January 1982, 21 (1) 181-186;
  8. Bourdeaux, M

    1. You have access
      Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;
  9. Briand, C

    1. You have access
      Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;
  10. Burch, R M

    1. You have access
      Inhibition of prostaglandin synthesis antagonizes the colchicine-induced reduction of vasopressin-stimulated water flow in the toad urinary bladder.
      R M Burch and P V Halushka
      Molecular Pharmacology January 1982, 21 (1) 142-149;
  11. Butcher, F R

    1. You have access
      Rat parotid gland protein kinase activation. Relationship to enzyme secretion.
      T N Spearman and F R Butcher
      Molecular Pharmacology January 1982, 21 (1) 121-127;
  12. Bylund, D B

    1. You have access
      Regulation of autonomic receptors in rat submandibular gland.
      D B Bylund, J R Martinez and D L Pierce
      Molecular Pharmacology January 1982, 21 (1) 27-35;

C

  1. Cha, S J

    1. You have access
      Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;
  2. Chabner, B A

    1. You have access
      Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
      C M Liang, R C Donehower and B A Chabner
      Molecular Pharmacology January 1982, 21 (1) 224-230;
  3. Champion, S

    1. You have access
      Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
      S Champion and J Mauchamp
      Molecular Pharmacology January 1982, 21 (1) 66-72;
    2. You have access
      Muscarinic cholinergic receptors on cultured thyroid cells. II. Carbachol-induced desensitization.
      S Champion and J Mauchamp
      Molecular Pharmacology January 1982, 21 (1) 73-77;
  4. Cheng, Y C

    1. You have access
      Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
      B A Domin, Y C Cheng and M T Hakala
      Molecular Pharmacology January 1982, 21 (1) 231-238;
  5. Chiu, T H

    1. You have access
      Kinetics of [3H]flunitrazepam binding to membrane-bound benzodiazepine receptors.
      T H Chiu, D M Dryden and H C Rosenberg
      Molecular Pharmacology January 1982, 21 (1) 57-65;
  6. Coon, M J

    1. You have access
      Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;
  7. Covey, D F

    1. You have access
      Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
      D F Covey and W F Hood
      Molecular Pharmacology January 1982, 21 (1) 173-180;
  8. Creese, I

    1. You have access
      Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
      M W Hamblin and I Creese
      Molecular Pharmacology January 1982, 21 (1) 44-51;
    2. You have access
      Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
      M W Hamblin and I Creese
      Molecular Pharmacology January 1982, 21 (1) 52-56;
  9. Crooke, S T

    1. You have access
      The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;

D

  1. De Clercq, E

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;
  2. De Lean, A

    1. You have access
      Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
      A De Lean, A A Hancock and R J Lefkowitz
      Molecular Pharmacology January 1982, 21 (1) 5-16;
  3. Descamps, J

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;
  4. Domin, B A

    1. You have access
      Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
      B A Domin, Y C Cheng and M T Hakala
      Molecular Pharmacology January 1982, 21 (1) 231-238;
  5. Donehower, R C

    1. You have access
      Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
      C M Liang, R C Donehower and B A Chabner
      Molecular Pharmacology January 1982, 21 (1) 224-230;
  6. Drummond, G S

    1. You have access
      The influence of organometals on heme metabolism. In vivo and in vitro studies with organotins.
      D W Rosenberg, G S Drummond and A Kappas
      Molecular Pharmacology January 1982, 21 (1) 150-158;
  7. Dryden, D M

    1. You have access
      Kinetics of [3H]flunitrazepam binding to membrane-bound benzodiazepine receptors.
      T H Chiu, D M Dryden and H C Rosenberg
      Molecular Pharmacology January 1982, 21 (1) 57-65;
  8. Dutta-Choudhury, T

    1. You have access
      Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
      D R Bickers, T Dutta-Choudhury and H Mukhtar
      Molecular Pharmacology January 1982, 21 (1) 239-247;
  9. DuVernay, V H

    1. You have access
      The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;

E

  1. Eling, T E

    1. You have access
      Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
      K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia
      Molecular Pharmacology January 1982, 21 (1) 133-141;
  2. Engelborghs, Y

    1. You have access
      Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;
  3. Eubanks, D

    1. You have access
      The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;

F

  1. Ferraiolo, B L

    1. You have access
      Subunit selectivity in the monooxygenase-like activity of tetrameric hemoglobin.
      B L Ferraiolo and J J Mieyal
      Molecular Pharmacology January 1982, 21 (1) 1-4;
  2. Filburn, C R

    1. You have access
      Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;
  3. Francis, P R

    1. You have access
      Biochemical and cell cycle perturbations in methotrexate-treated cells.
      I W Taylor, P Slowiaczek, P R Francis and M H Tattersall
      Molecular Pharmacology January 1982, 21 (1) 204-210;

G

  1. Gelboin, H V

    1. You have access
      Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;
  2. Gespach, C

    1. You have access
      Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP.
      C Gespach and J P Abita
      Molecular Pharmacology January 1982, 21 (1) 78-85;
  3. Gilli, R

    1. You have access
      Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;
  4. Goulian, M

    1. You have access
      Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
      H A Ingraham, B Y Tseng and M Goulian
      Molecular Pharmacology January 1982, 21 (1) 211-216;

H

  1. Hakala, M T

    1. You have access
      Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
      B A Domin, Y C Cheng and M T Hakala
      Molecular Pharmacology January 1982, 21 (1) 231-238;
  2. Halpert, J

    1. You have access
      Further studies of the suicide inactivation of purified rat liver cytochrome P-450 by chloramphenicol.
      J Halpert
      Molecular Pharmacology January 1982, 21 (1) 166-172;
  3. Halushka, P V

    1. You have access
      Inhibition of prostaglandin synthesis antagonizes the colchicine-induced reduction of vasopressin-stimulated water flow in the toad urinary bladder.
      R M Burch and P V Halushka
      Molecular Pharmacology January 1982, 21 (1) 142-149;
  4. Hamblin, M W

    1. You have access
      Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
      M W Hamblin and I Creese
      Molecular Pharmacology January 1982, 21 (1) 44-51;
    2. You have access
      Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
      M W Hamblin and I Creese
      Molecular Pharmacology January 1982, 21 (1) 52-56;
  5. Hancock, A A

    1. You have access
      Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
      A De Lean, A A Hancock and R J Lefkowitz
      Molecular Pharmacology January 1982, 21 (1) 5-16;
  6. Hanna, P E

    1. You have access
      Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
      P E Hanna, R B Banks and V C Marhevka
      Molecular Pharmacology January 1982, 21 (1) 159-165;
  7. Haubrich, D R

    1. You have access
      The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
      D R Haubrich and A B Pflueger
      Molecular Pharmacology January 1982, 21 (1) 114-120;
  8. Hoebeke, J

    1. You have access
      Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;
  9. Hood, W F

    1. You have access
      Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
      D F Covey and W F Hood
      Molecular Pharmacology January 1982, 21 (1) 173-180;
  10. Hopfinger, A J

    1. You have access
      Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.
      A J Hopfinger and R Potenzone
      Molecular Pharmacology January 1982, 21 (1) 187-195;
  11. Huang, G F

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;
  12. Huber, J A

    1. You have access
      Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
      R T Borchardt, D Kuonen, J A Huber and A Moorman
      Molecular Pharmacology January 1982, 21 (1) 181-186;

I

  1. Ingraham, H A

    1. You have access
      Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
      H A Ingraham, B Y Tseng and M Goulian
      Molecular Pharmacology January 1982, 21 (1) 211-216;
  2. Insel, P A

    1. You have access
      Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
      J S Karliner, H J Motulsky and P A Insel
      Molecular Pharmacology January 1982, 21 (1) 36-43;
  3. Ito, H

    1. You have access
      Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;

J

  1. Jones, A S

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

K

  1. Kahn, D J

    1. You have access
      Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase.
      D J Kahn, J C Mitrius and D C U'Prichard
      Molecular Pharmacology January 1982, 21 (1) 17-26;
  2. Kappas, A

    1. You have access
      The influence of organometals on heme metabolism. In vivo and in vitro studies with organotins.
      D W Rosenberg, G S Drummond and A Kappas
      Molecular Pharmacology January 1982, 21 (1) 150-158;
  3. Karliner, J S

    1. You have access
      Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
      J S Karliner, H J Motulsky and P A Insel
      Molecular Pharmacology January 1982, 21 (1) 36-43;
  4. Kuonen, D

    1. You have access
      Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
      R T Borchardt, D Kuonen, J A Huber and A Moorman
      Molecular Pharmacology January 1982, 21 (1) 181-186;

L

  1. Lasker, J M

    1. You have access
      Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
      K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia
      Molecular Pharmacology January 1982, 21 (1) 133-141;
  2. Lefkowitz, R J

    1. You have access
      Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
      A De Lean, A A Hancock and R J Lefkowitz
      Molecular Pharmacology January 1982, 21 (1) 5-16;
  3. Liang, C M

    1. You have access
      Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
      C M Liang, R C Donehower and B A Chabner
      Molecular Pharmacology January 1982, 21 (1) 224-230;

M

  1. Maes, V

    1. You have access
      Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;
  2. Maras, Y

    1. You have access
      Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;
  3. Marhevka, V C

    1. You have access
      Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
      P E Hanna, R B Banks and V C Marhevka
      Molecular Pharmacology January 1982, 21 (1) 159-165;
  4. Martinez, J R

    1. You have access
      Regulation of autonomic receptors in rat submandibular gland.
      D B Bylund, J R Martinez and D L Pierce
      Molecular Pharmacology January 1982, 21 (1) 27-35;
  5. Mauchamp, J

    1. You have access
      Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
      S Champion and J Mauchamp
      Molecular Pharmacology January 1982, 21 (1) 66-72;
    2. You have access
      Muscarinic cholinergic receptors on cultured thyroid cells. II. Carbachol-induced desensitization.
      S Champion and J Mauchamp
      Molecular Pharmacology January 1982, 21 (1) 73-77;
  6. Mieyal, J J

    1. You have access
      Subunit selectivity in the monooxygenase-like activity of tetrameric hemoglobin.
      B L Ferraiolo and J J Mieyal
      Molecular Pharmacology January 1982, 21 (1) 1-4;
  7. Miller, H

    1. You have access
      Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;
  8. Mitrius, J C

    1. You have access
      Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase.
      D J Kahn, J C Mitrius and D C U'Prichard
      Molecular Pharmacology January 1982, 21 (1) 17-26;
  9. Moorman, A

    1. You have access
      Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
      R T Borchardt, D Kuonen, J A Huber and A Moorman
      Molecular Pharmacology January 1982, 21 (1) 181-186;
  10. Motulsky, H J

    1. You have access
      Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
      J S Karliner, H J Motulsky and P A Insel
      Molecular Pharmacology January 1982, 21 (1) 36-43;
  11. Mukhtar, H

    1. You have access
      Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
      D R Bickers, T Dutta-Choudhury and H Mukhtar
      Molecular Pharmacology January 1982, 21 (1) 239-247;

P

  1. Park, S S

    1. You have access
      Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;
  2. Perales, R

    1. You have access
      The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;
  3. Persson, A V

    1. You have access
      Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
      S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
      Molecular Pharmacology January 1982, 21 (1) 248-258;
  4. Peyrot, V

    1. You have access
      Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;
  5. Pflueger, A B

    1. You have access
      The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
      D R Haubrich and A B Pflueger
      Molecular Pharmacology January 1982, 21 (1) 114-120;
  6. Pierce, D L

    1. You have access
      Regulation of autonomic receptors in rat submandibular gland.
      D B Bylund, J R Martinez and D L Pierce
      Molecular Pharmacology January 1982, 21 (1) 27-35;
  7. Potenzone, R

    1. You have access
      Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.
      A J Hopfinger and R Potenzone
      Molecular Pharmacology January 1982, 21 (1) 187-195;
  8. Prestayko, A W

    1. You have access
      The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
      V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
      Molecular Pharmacology January 1982, 21 (1) 196-203;

R

  1. Rosenberg, D W

    1. You have access
      The influence of organometals on heme metabolism. In vivo and in vitro studies with organotins.
      D W Rosenberg, G S Drummond and A Kappas
      Molecular Pharmacology January 1982, 21 (1) 150-158;
  2. Rosenberg, H C

    1. You have access
      Kinetics of [3H]flunitrazepam binding to membrane-bound benzodiazepine receptors.
      T H Chiu, D M Dryden and H C Rosenberg
      Molecular Pharmacology January 1982, 21 (1) 57-65;
  3. Roth, G S

    1. You have access
      Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;

S

  1. Sacktor, B

    1. You have access
      Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;
  2. Sari, J C

    1. You have access
      Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;
  3. Sarrazin, M

    1. You have access
      Study of the interaction between human serum albumin and some cephalosporins.
      C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
      Molecular Pharmacology January 1982, 21 (1) 92-99;
  4. Sellinger-Barnette, M

    1. You have access
      Interaction of beta-endorphin and other opioid peptides with calmodulin.
      M Sellinger-Barnette and B Weiss
      Molecular Pharmacology January 1982, 21 (1) 86-91;
  5. Serafinowski, P

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;
  6. Sivarajah, K

    1. You have access
      Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
      K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia
      Molecular Pharmacology January 1982, 21 (1) 133-141;
  7. Slowiaczek, P

    1. You have access
      Biochemical and cell cycle perturbations in methotrexate-treated cells.
      I W Taylor, P Slowiaczek, P R Francis and M H Tattersall
      Molecular Pharmacology January 1982, 21 (1) 204-210;
  8. Spearman, T N

    1. You have access
      Rat parotid gland protein kinase activation. Relationship to enzyme secretion.
      T N Spearman and F R Butcher
      Molecular Pharmacology January 1982, 21 (1) 121-127;

T

  1. Tattersall, M H

    1. You have access
      Biochemical and cell cycle perturbations in methotrexate-treated cells.
      I W Taylor, P Slowiaczek, P R Francis and M H Tattersall
      Molecular Pharmacology January 1982, 21 (1) 204-210;
  2. Taylor, I W

    1. You have access
      Biochemical and cell cycle perturbations in methotrexate-treated cells.
      I W Taylor, P Slowiaczek, P R Francis and M H Tattersall
      Molecular Pharmacology January 1982, 21 (1) 204-210;
  3. Torrence, P F

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;
  4. Tseng, B Y

    1. You have access
      Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
      H A Ingraham, B Y Tseng and M Goulian
      Molecular Pharmacology January 1982, 21 (1) 211-216;

U

  1. U'Prichard, D C

    1. You have access
      Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase.
      D J Kahn, J C Mitrius and D C U'Prichard
      Molecular Pharmacology January 1982, 21 (1) 17-26;
  2. Uchida, T

    1. You have access
      Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
      T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
      Molecular Pharmacology January 1982, 21 (1) 128-132;
  3. Ueland, P M

    1. You have access
      Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purified rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine.
      P M Ueland, J Aarbakke and A Bessesen
      Molecular Pharmacology January 1982, 21 (1) 108-113;

V

  1. Vercruysse, A

    1. You have access
      Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
      V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
      Molecular Pharmacology January 1982, 21 (1) 100-107;
  2. Verhelst, G

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;

W

  1. Walker, R T

    1. You have access
      Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
      E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
      Molecular Pharmacology January 1982, 21 (1) 217-223;
  2. Weiss, B

    1. You have access
      Interaction of beta-endorphin and other opioid peptides with calmodulin.
      M Sellinger-Barnette and B Weiss
      Molecular Pharmacology January 1982, 21 (1) 86-91;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 21, Issue 1
1 Jan 1982
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics